Eli Lilly Breaks Barriers: First Pharma Company Valued at $1 Trillion . . . Eli Lilly has cemented its place in pharmaceutical history by reaching an unprecedented market value of $1 trillion on November 21, 2025 This landmark achievement underscores the transformative impact of its innovative obesity treatments, such as Zepbound and Mounjaro, which have propelled the company to the forefront of the industry With combined sales nearing $19 billion in just the first
Eli Lilly hits $1 trillion market value as weight-loss drugs soar Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse A more than 35% rally in the company’s stock this year has largely been driven by the explosive growth of the weight-loss drug market